Singapore, Aug 13, 2010: Technology Vision Group (TVG) has announced that leaders of the pharma industry will gather in London on October 11-12, 2010, seeking partnering opportunities with biotechnology companies at the 18th Annual BioPartnering Europe conference.

Two of the top decision-makers in the pharma industry, Dr David Nicholson, senior vice president, Worldwide Licensing and Knowledge Management, Merck & Co., and Dr Anders Ekblom, executive vice president, Global Medicines Development at AstraZeneca, will address the event.

"Pharma companies are already executing transformational strategies that are defining the future of the life sciences industry. BioPartnering Europe is a catalyst for that transformation, bringing together the power players who are driving change, forging new alliances in new markets, and redefining how business is done. The event is a critical strategic moment for industry leaders focused on advancing their pipeline and pursuing partnerships," Dr Robert Lee Kilpatrick, partner, TVG.